are semaglutides dangerous Why buying weight loss drugs without a prescription is risky FBI issues safety warning about
Description
The first step is to schedule a consultation to find which medication may be appropriate for you
Clinical evidence The STEP 1 trial showed participants achieved an average 14.9% weight loss over 68 weeks with semaglutide 2.4 mg
Common adverse events associated with semaglutide use include gastrointestinal symptoms such as nausea, vomiting, diarrhea, and abdominal pain, which are typically mild to moderate in severity and transient in nature
Verify your measurement
